Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yin Yang Gong Ji pill is a Traditional Chinese Medicine (TCM) formulation developed for the treatment of advanced malignancies, specifically metastatic colorectal cancer. The name reflects the TCM therapeutic strategy of balancing "Yin" and "Yang" while "attacking accumulations" (Gong Ji), a term used to describe the reduction of tumor masses. It is typically administered as an adjuvant therapy to standard-of-care chemotherapy. Clinical research, such as trial ChiCTR2300077794, investigates its efficacy in improving progression-free survival and quality of life in patients with colorectal cancer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yin Yang Gong Ji pill.